10th Biennial Helene Harris Memorial Trust Meeting

Frances R. Balkwill, Alan Ashworth, Robert C. Bast, Jonathon S. Berek, Jeff Boyd, Mary L. Disis, Hani Gabra, Martin E. Gore, Thomas C. Hamilton, Ian J. Jacobs, Stan B. Kaye, Elise C. Kohn, Gordon B. Mills, Nicole D. Urban

    Research output: Contribution to journalArticle

    Abstract

    Improving the prognosis of ovarian cancer patients is a major challenge to scientists and clinicians. At a recent multidisciplinary meeting in Washington DC, advances in identification of precursor lesions, progress in disease biomarkers and animal models, the promise of nanotechnology, and strategies for manipulation of the innate and adaptive immune response offered prospects for real progress in this difficult-to-treat disease.

    Original languageEnglish (US)
    Pages (from-to)2904-2906
    Number of pages3
    JournalCancer Research
    Volume66
    Issue number6
    DOIs
    StatePublished - Mar 15 2006

      Fingerprint

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research

    Cite this

    Balkwill, F. R., Ashworth, A., Bast, R. C., Berek, J. S., Boyd, J., Disis, M. L., Gabra, H., Gore, M. E., Hamilton, T. C., Jacobs, I. J., Kaye, S. B., Kohn, E. C., Mills, G. B., & Urban, N. D. (2006). 10th Biennial Helene Harris Memorial Trust Meeting. Cancer Research, 66(6), 2904-2906. https://doi.org/10.1158/0008-5472.CAN-05-2093